For instance, these genetic events are predominant in thyroid cancer carrying the mutation in the genes of the RAS-BRAF signalling pathway, and in glioblastoma with the mutation in the IDH1 gene [14,30]. The gene discussed is IDH1; the disease is glioblastoma.